Cargando…

Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?

PURPOSE: We evaluated the negative predictive value (NPV) of multiparametric magnetic resonance imaging (mpMRI) in detecting clinically significant prostate cancer (csPCa) according to biopsy setting and prostate-specific antigen density (PSAD) using transperineal template-guided saturation prostate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jiwoong, Boo, Youngjun, Kang, Minyong, Sung, Hyun Hwan, Jeong, Byong Chang, Seo, Seongil, Jeon, Seong soo, Lee, Hyunmoo, Jeon, Hwang Gyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275136/ https://www.ncbi.nlm.nih.gov/pubmed/34262353 http://dx.doi.org/10.2147/CMAR.S318404

Ejemplares similares

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
por: Leow, Jeffrey J, et al.
Publicado: (2022)

Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)
por: Chung, Jae Hoon, et al.
Publicado: (2020)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
por: Song, Wan, et al.
Publicado: (2019)

Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance
por: Yu, Jiwoong, et al.
Publicado: (2021)

The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
por: Lee, Chung Un, et al.
Publicado: (2021)

Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
por: Ryoo, Hyunsoo, et al.
Publicado: (2020)

Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1–2 on multiparametric magnetic resonance imaging
por: Lee, Chung Un, et al.
Publicado: (2022)

Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5–10 ng/mL
por: Choi, Joongwon, et al.
Publicado: (2020)

Omitting the systematic prostate biopsy: ready for prime time?
por: Leong, Joon Yau, et al.
Publicado: (2023)

Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions
por: Lee, Chung-Un, et al.
Publicado: (2022)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

Prognostic Factors and Clinical Outcomes of Urological Soft Tissue Sarcomas
por: Lee, Geonseok, et al.
Publicado: (2011)

Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study
por: Kim, Jun Seop, et al.
Publicado: (2023)

Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy
por: Kim, Tae Sun, et al.
Publicado: (2015)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities
por: Chung, Jae Hoon, et al.
Publicado: (2021)

Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer
por: Lee, Ji Hyun, et al.
Publicado: (2021)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

Frozen section utilization to omit systematic biopsy in diagnosing high risk prostate cancer
por: Tae, Jong Hyun, et al.
Publicado: (2022)

Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value
por: Chung, Jae Hoon, et al.
Publicado: (2021)

Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing
por: Kang, Minyong, et al.
Publicado: (2019)

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value
por: Chung, Jae Hoon, et al.
Publicado: (2022)

Interval from Prostate Biopsy to Radical Prostatectomy Does Not Affect Immediate Operative Outcomes for Open or Minimally Invasive Approach
por: Park, Bumsoo, et al.
Publicado: (2014)

Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision‐making processes
por: Long, Xingbo, et al.
Publicado: (2020)

Comparison of Efficacy of Different Surgical Techniques for Benign Prostatic Obstruction
por: Yu, Jiwoong, et al.
Publicado: (2021)

Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels
por: Yang, Jin Bak, et al.
Publicado: (2010)

Author Correction: Frozen section utilization to omit systematic biopsy in diagnosing high risk prostate cancer
por: Tae, Jong Hyun, et al.
Publicado: (2022)

Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients
por: Yu, Jiwoong, et al.
Publicado: (2018)

Can expressed prostatic secretions affect prostate biopsy decision of urologist?
por: Ergün, Osman, et al.
Publicado: (2019)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy
por: Choi, Young Hyo, et al.
Publicado: (2023)

The utility of two-dimensional shear wave elastography for predicting prostate cancer: a preliminary study
por: Jeon, Seong Soo, et al.
Publicado: (2023)

Can natural killer cell activity help screen patients requiring a biopsy for the diagnosis of prostate cancer?
por: Tae, Bum Sik, et al.
Publicado: (2020)

Clinical significance of the De Ritis ratio for detecting prostate cancer in a repeat prostate biopsy
por: Ha, Heon, et al.
Publicado: (2019)

Poly (ADP-ribose) polymerase inhibitor: A new horizon in advanced prostate cancer treatment
por: Kang, Minyong, et al.
Publicado: (2023)

Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer
por: Lee, Chung-Un, et al.
Publicado: (2022)

Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance
por: Choo, Seol Ho, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_afgue927eq26p44qjng6l87gna